Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.
about
Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventionsThe contributory role of gut microbiota in cardiovascular diseaseThe aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney diseasePrognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate.AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving HemodialysisContinuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis PatientsAtherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.Novel drugs and intervention strategies for the treatment of chronic kidney disease.Targeting protein-bound uremic toxins in chronic kidney disease.Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome.Adjusted Anion Gap Is Associated with Glomerular Filtration Rate Decline in Chronic Kidney DiseaseThe uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.Targeting Immunity in End-Stage Renal Disease.Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
P2860
Q26751203-7B8F9220-4FEC-45F1-A10D-FB5D31A53A55Q26830828-5F3E7E15-8697-408B-BAD0-8873DC27D29FQ28382992-C0929459-3447-4FDB-9A63-9D240F01101AQ34625372-34CB80CF-AAD5-472B-91D2-3E954142C4FFQ35581624-C5C0017D-8095-4DE2-A8C1-56949A5CA798Q35798608-8B86CC33-96EF-45AD-8739-ABA01290477CQ35996626-EC9A0408-5A0B-4E07-BB61-65310C2D0941Q36020478-5B9A13C7-041A-4E2E-AD1E-C511823646E6Q36099390-69E31420-FFD7-4371-94F9-7AAC918F8863Q36851491-6ECBB9ED-1F64-4710-B2D8-5D55BC0E5299Q37219043-D5BAA2D3-2B1C-4672-88E3-4849BB1ED926Q38128596-F22CE903-0FBB-458B-BAA5-1B86ED2B9DD7Q38190366-450281DC-CB9F-4946-83C8-A891CFBE20CFQ38218395-874B870B-BEA2-4C47-90C3-A51F649FA282Q38826236-9AF95CE7-5589-43E8-92ED-AE9F15D2FB1FQ42682778-BC71DED4-866D-45D7-898E-FC4DAA48B043Q47851147-453F14DA-45D4-4C3C-9DF1-84FC47855114Q50872135-44119227-6B37-4DCA-B387-F43D0C9524ECQ52726373-BFE8B8FA-57F2-449D-B0A6-1FDCAB058435Q58749760-89DBA667-5B3C-4AD6-AF07-56FD8D811917Q58773641-1450EFA8-253B-4512-927B-D48AB7FD69B5
P2860
Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oral activated charcoal adsorb ...... olipoprotein E-deficient mice.
@ast
Oral activated charcoal adsorb ...... olipoprotein E-deficient mice.
@en
type
label
Oral activated charcoal adsorb ...... olipoprotein E-deficient mice.
@ast
Oral activated charcoal adsorb ...... olipoprotein E-deficient mice.
@en
prefLabel
Oral activated charcoal adsorb ...... olipoprotein E-deficient mice.
@ast
Oral activated charcoal adsorb ...... olipoprotein E-deficient mice.
@en
P2093
P2860
P356
P1476
Oral activated charcoal adsorb ...... olipoprotein E-deficient mice.
@en
P2093
Agnes B Fogo
Iekuni Ichikawa
Macrae F Linton
Masaru Motojima
Patricia G Yancey
Sergio Fazio
Suguru Yamamoto
Tracy E Hunley
Valentina Kon
P2860
P304
P356
10.1093/NDT/GFQ759
P407
P577
2011-01-18T00:00:00Z